We are live on ! Find out more
FIA

FNY Investment Advisers Portfolio holdings

AUM $278M
1-Year Est. Return 98.99%
This Fund
S&P 500
This Quarter Est. Return
+15.53%
1 Year Est. Return
+98.99%
3 Year Est. Return
+307.32%
5 Year Est. Return
+396.61%
10 Year Est. Return
AUM
$87.4M
AUM Growth
+$15.7M
Cap. Flow
+$13.1M
Cap. Flow %
14.97%
Top 10 Hldgs %
42.53%
Holding
870
New
303
Increased
61
Reduced
108
Closed
254

Top Sells

Rank Stock Value
1
AMZN icon
Amazon
AMZN
+$1.89M
2
VMW
VMware, Inc
VMW
+$1.8M
3
VIVO
Meridian Bioscience Inc
VIVO
+$1.69M
4
CMBT
CMB.TECH NV
CMBT
+$1.68M
5
LI icon
Li Auto
LI
+$1.62M

Sector Composition

Rank Sector Weight
1 Healthcare 23.03%
2 Technology 17.85%
3 Industrials 13.58%
4 Communication Services 8.63%
5 Financials 8.26%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
OPGN
151
DELISTED
OpGen, Inc
OPGN
$67K 0.08%
5,089
+4,676
+1,132% +$77.5K
BXMX
152
DELISTED
Nuveen S&P 500 Buy-Write Income Fund
BXMX
$65K 0.07%
+5,000
New +$65.4K
DB icon
153
Deutsche Bank
DB
$71.8B
$65K 0.07%
+6,449
New +$77.1K
ATH.PRD
154
Athene Holding Ltd Series D
ATH.PRD
$366M
$64K 0.07%
+4,100
New +$75.1K
INMD icon
155
InMode
INMD
$870M
$62K 0.07%
+1,966
New +$67.3K
SCYX icon
156
SCYNEXIS
SCYX
$48.1M
$61K 0.07%
+2,574
New +$34.2K
XLK icon
157
State Street Technology Select Sector SPDR ETF
XLK
$122B
$61K 0.07%
+816
New +$56.2K
TEN.PRF
158
Tsakos Energy Navigation Ltd Series F Preferred Shares
TEN.PRF
$180M
$60K 0.07%
2,439
VVX icon
159
V2X
VVX
$2.52B
$59K 0.07%
1,500
-500
-25% -$21.4K
MP icon
160
MP Materials
MP
$9.84B
$57K 0.07%
2,033
+1,039
+105% +$31.4K
BIIB icon
161
Biogen
BIIB
$30.1B
$56K 0.06%
204
+104
+104% +$28.8K
GMED icon
162
Globus Medical
GMED
$11.4B
$56K 0.06%
+1,000
New +$64.1K
GLDD
163
DELISTED
Great Lakes Dredge & Dock
GLDD
$54K 0.06%
+10,000
New +$59.9K
GRAB icon
164
Grab
GRAB
$15.3B
$54K 0.06%
18,200
-5,500
-23% -$18.3K
CCJ icon
165
Cameco
CCJ
$43B
$53K 0.06%
2,033
-1,367
-40% -$36.1K
CGC
166
Canopy Growth
CGC
$422M
$52K 0.06%
+3,000
New +$71.2K
QID icon
167
ProShares UltraShort QQQ
QID
$251M
$52K 0.06%
+600
New +$63.4K
SBGI icon
168
Sinclair Inc
SBGI
$989M
$51K 0.06%
3,000
-4,500
-60% -$78.3K
IMMR icon
169
Immersion
IMMR
$248M
$50K 0.06%
+5,684
New +$43K
SWN
170
DELISTED
Southwestern Energy Company
SWN
$50K 0.06%
+10,000
New +$53K
AMD icon
171
Advanced Micro Devices
AMD
$774B
$49K 0.06%
510
+500
+5,000% +$40.7K
SMLR
172
DELISTED
Semler Scientific
SMLR
$49K 0.06%
+1,842
New +$51.6K
NUVA
173
DELISTED
NuVasive, Inc.
NUVA
$49K 0.06%
+1,200
New +$51.3K
CRK icon
174
Comstock Resources
CRK
$4.23B
$48K 0.05%
+4,500
New +$53.5K
IRBT
175
DELISTED
iRobot
IRBT
$48K 0.05%
1,100
-5,250
-83% -$232K

Similar funds

FNY Investment Advisers's Q1 2023 Portfolio in Review

As of Q1 2023, FNY Investment Advisers held 870 positions worth $87.4M, up 22% from $71.6M the previous quarter. Its ten largest holdings account for 43% of the portfolio.

FNY Investment Advisers deployed $13.1M of net new capital in Q1 2023, opening 303 new positions and adding to 61 existing holdings. Its largest new stake was Oak Street Health, Inc.: 211,646 shares worth $8.19M.

By sector, the portfolio is most concentrated in Healthcare at 23% of assets, up from 5.3% a quarter earlier, followed by Technology and Industrials.

On the sell side, the largest reduction was Amazon, an estimated $1.89M trimmed.

  • FNY Investment Advisers's largest Q1 2023 buy was Oak Street Health, Inc.: 211,646 shares worth $8.19M.
  • FNY Investment Advisers added most to Horizon Therapeutics Public Limited Company Ordinary Shares in Q1 2023, an estimated $6.29M increase.
  • FNY Investment Advisers's biggest Q1 2023 reduction was Amazon, cutting an estimated $1.89M.
  • FNY Investment Advisers fully exited Meridian Bioscience Inc in Q1 2023, selling an estimated $1.69M.
  • FNY Investment Advisers's ten largest holdings make up 43% of its $87.4M portfolio in Q1 2023.
  • FNY Investment Advisers opened 303 new positions and closed 254 in Q1 2023.
  • FNY Investment Advisers's portfolio value rose 22% quarter-over-quarter to $87.4M.

Based on FNY Investment Advisers's 13F filing for Q1 2023, filed 12 Apr 2023.